// =============================================================================
// Strategic Claim Content for Aurivian x Nestle Health Science VMHS Demo
// Pre-analyzed strategic intelligence for claim substantiation
// Ingredients: Magnesium+Sleep, Red Clover+Menopause, Collagen+Skin Elasticity
// =============================================================================

export const EVIDENCE_LANDSCAPE = {
  marketOverview: {
    globalVMHSMarket: {
      valuation: "$167.8 billion (2025)",
      projectedGrowth: "CAGR 7.1% through 2030",
      keyDrivers: [
        "Post-pandemic consumer interest in preventive health",
        "Aging global population seeking functional solutions",
        "Rise of personalized nutrition and targeted supplementation",
        "Digital health integration driving consumer education",
        "Increased clinical evidence standards from major brands",
      ],
      consumerTrends: {
        evidenceAwareness:
          "72% of supplement consumers now seek clinically backed claims (Nutrition Business Journal, 2025)",
        formPreference:
          "Shift toward bioavailable forms (chelated minerals, peptides) over commodity ingredients",
        transparencyDemand:
          "65% of consumers prefer brands that disclose sourcing and clinical evidence",
        personalization:
          "Growing demand for condition-specific, age-specific, and gender-specific formulations",
      },
    },
    nestleHealthSciencePosition: {
      portfolioBrands: [
        "Pure Encapsulations",
        "Solgar",
        "Nature's Bounty",
        "Vital Proteins",
        "Garden of Life",
        "Nuun",
        "Orgain",
      ],
      strategicAdvantage:
        "Largest diversified VMHS portfolio globally, spanning premium clinical-grade (Pure Encapsulations) through mass-market (Nature's Bounty) channels",
      evidenceInvestment:
        "Estimated $45M+ annual R&D investment across VMHS clinical programs",
    },
  },

  regulatoryLandscape: {
    unitedStates: {
      framework: "DSHEA (Dietary Supplement Health and Education Act of 1994)",
      claimTypes: {
        structureFunction: {
          statute: "21 CFR 101.93",
          description:
            "Claims describing the role of a nutrient or dietary ingredient intended to affect the structure or function of the body",
          requirements: [
            "Substantiation must exist prior to making the claim",
            "Must include standard disclaimer: 'This statement has not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease.'",
            "FDA notification required within 30 days of first marketing",
            "Must not imply disease treatment or prevention",
          ],
          substantiationStandard:
            "Competent and reliable scientific evidence - typically interpreted as agreement among qualified experts that the evidence supports the claim",
        },
        nutrientContent: {
          description:
            "Claims characterizing the level of a nutrient (e.g., 'high in magnesium')",
          requirements: [
            "Must meet FDA-defined thresholds per 21 CFR 101.54",
            "Serving size and daily value calculations must comply",
          ],
        },
        qualifiedHealthClaims: {
          description:
            "Claims supported by some but not conclusive scientific evidence",
          requirements: [
            "FDA petition and review required",
            "Qualifying language must accompany the claim",
            "Letter of enforcement discretion from FDA",
          ],
        },
      },
      enforcementTrends: [
        "FTC increasing scrutiny on substantiation adequacy for supplement claims",
        "NAD (National Advertising Division) challenges rising 18% year-over-year",
        "State AG offices (particularly NY, CA) pursuing supplement claim enforcement",
        "Amazon and retail platform claim verification becoming de facto gatekeepers",
      ],
    },
    europeanUnion: {
      framework: "Regulation (EC) No 1924/2006 on Nutrition and Health Claims",
      efsaProcess: {
        description:
          "European Food Safety Authority evaluates all health claim applications under Article 13 and Article 14",
        approvalRate:
          "Approximately 12% of submitted health claims have received positive EFSA opinions",
        keyRequirements: [
          "Well-characterized substance with defined conditions of use",
          "Beneficial physiological effect demonstrated in target population",
          "Human intervention studies (preferably RCTs) as primary evidence",
          "Cause-and-effect relationship established",
          "Claimed effect achievable at proposed intake level",
        ],
      },
      authorizedClaims: {
        magnesium: [
          "Magnesium contributes to a reduction of tiredness and fatigue (EU Register 2012)",
          "Magnesium contributes to normal functioning of the nervous system",
          "Magnesium contributes to normal psychological function",
          "Magnesium contributes to normal muscle function",
          "Magnesium contributes to electrolyte balance",
        ],
        collagen: [
          "No authorized health claims for collagen peptides as of 2025",
          "Vitamin C contributes to normal collagen formation (used as proxy claim pathway)",
        ],
        redClover: [
          "No authorized Article 13.1 health claims for red clover",
          "Isoflavone claims remain under evaluation; botanical claims in regulatory limbo under the 'on hold' list since 2010",
        ],
      },
    },
    otherMarkets: {
      canada: {
        framework: "Natural Health Products Regulations (NHPR)",
        authority: "Natural and Non-prescription Health Products Directorate (NNHPD)",
        relevance:
          "Monograph-based system provides pre-approved claim templates for common ingredients including magnesium and collagen",
      },
      australia: {
        framework: "Therapeutic Goods Act 1989",
        authority: "Therapeutic Goods Administration (TGA)",
        relevance:
          "Listed medicines (AUST L) allow pre-approved low-level claims; assessed medicines (AUST R) for higher-level therapeutic claims",
      },
      japan: {
        framework: "Foods with Function Claims (FFC) system since 2015",
        relevance:
          "Self-notification system with systematic review requirements provides model for evidence-based claim substantiation",
      },
    },
  },

  keyEvidenceChallenges: {
    totalityOfEvidence: {
      description:
        "Claim substantiation requires assessment of the totality of publicly available scientific evidence, not just cherry-picked positive trials",
      challenges: [
        "Negative or null studies must be weighed and addressed",
        "Pre-clinical and mechanistic data plays supporting but not primary role",
        "Observational studies contribute to evidence weight but cannot establish causation alone",
        "Systematic reviews and meta-analyses carry highest evidence weight",
      ],
    },
    formSpecificData: {
      description:
        "Different forms of the same ingredient (e.g., magnesium glycinate vs. magnesium oxide) may have vastly different bioavailability and clinical evidence profiles",
      challenges: [
        "Bridging data between forms is scientifically complex",
        "Regulators increasingly expect form-specific substantiation",
        "Consumer confusion about form differences creates both risk and opportunity",
        "Supply chain decisions (cost of raw materials) may conflict with evidence-strongest forms",
      ],
    },
    multilingualStudies: {
      description:
        "Relevant clinical evidence exists across multiple languages (Japanese, Korean, German, Portuguese) requiring systematic multilingual literature review",
      challenges: [
        "Standard English-only PubMed searches miss 15-30% of relevant evidence",
        "Japanese FFC dossiers contain valuable unpublished data",
        "German Commission E monographs remain influential for botanical claims",
        "Chinese and Korean traditional medicine databases contain relevant mechanistic data",
      ],
    },
  },

  emergingResearchThemes: [
    {
      theme: "Gut-Brain Axis and Sleep",
      relevance: "Magnesium+Sleep",
      description:
        "Emerging evidence on magnesium's role in modulating the gut-brain axis via GABA receptor activity, connecting mineral supplementation to sleep architecture improvements",
      keyPublications:
        "Multiple 2024-2025 RCTs exploring magnesium's effects on sleep onset latency and sleep quality via Pittsburgh Sleep Quality Index (PSQI)",
    },
    {
      theme: "Phytoestrogen Selectivity",
      relevance: "Red Clover+Menopause",
      description:
        "New understanding of isoflavone selectivity for estrogen receptor beta (ER-beta) vs. ER-alpha, supporting safety profile and tissue-specific activity",
      keyPublications:
        "Updated systematic reviews in Maturitas and Climacteric journals (2023-2025) with improved methodology",
    },
    {
      theme: "Collagen Peptide Bioactivity",
      relevance: "Collagen+Skin Elasticity",
      description:
        "Dipeptide and tripeptide fragments (Pro-Hyp, Hyp-Gly) shown to act as bioactive signaling molecules, not just amino acid sources, stimulating fibroblast activity",
      keyPublications:
        "Japanese Journal of Food Chemistry and Safety, Journal of Agricultural and Food Chemistry, multiple RCTs using specific collagen peptide molecular weight fractions",
    },
    {
      theme: "Chronobiology and Nutrient Timing",
      relevance: "Cross-ingredient",
      description:
        "Growing evidence that timing of supplement intake (morning vs. evening, with meals vs. fasting) significantly impacts efficacy, particularly for magnesium and sleep",
    },
    {
      theme: "Digital Biomarker Validation",
      relevance: "Cross-ingredient",
      description:
        "Wearable devices (Oura, WHOOP, Apple Watch) providing objective sleep and skin metrics that may supplement traditional PROs (Patient-Reported Outcomes) in future clinical trials",
    },
  ],
};

export const INGREDIENT_POSITIONING = {
  magnesiumSleep: {
    ingredient: "Magnesium",
    claimArea: "Sleep Quality & Sleep Support",
    evidenceStrength: {
      rating: "Moderate-to-Strong",
      score: 7.5,
      scaleDescription: "1-10, where 10 = multiple large RCTs with consistent positive outcomes",
      rationale:
        "Multiple RCTs demonstrate statistically significant improvements in subjective sleep quality (PSQI). Evidence strongest for magnesium glycinate and magnesium bisglycinate forms. Meta-analyses support a modest but consistent effect. Mechanistic pathway well-characterized via GABA modulation and HPA axis regulation.",
      keyLimitations: [
        "Most RCTs are small (n=40-100) with short duration (8-12 weeks)",
        "Heterogeneity in forms, doses, and populations across studies",
        "Limited objective sleep measurement (PSG) data; most rely on self-reported PSQI",
        "Dose-response relationship not fully established across forms",
      ],
    },
    competitiveLandscape: {
      nestleBrands: {
        pureEncapsulations: {
          currentProducts: [
            "Magnesium (Glycinate)",
            "Magnesium (Citrate)",
            "UltraMag Magnesium",
          ],
          positioning: "Premium clinical-grade, hypoallergenic, practitioner-recommended",
          claimApproach: "Conservative, evidence-first, references bioavailability studies",
          strengthVsCompetitors:
            "Strongest clinical credibility among HCPs; glycinate form aligns with best-evidenced form for sleep",
        },
        solgar: {
          currentProducts: [
            "Magnesium Citrate",
            "Chelated Magnesium",
            "Magnesium with Vitamin B6",
          ],
          positioning: "Heritage brand, quality-focused, broad consumer appeal",
          claimApproach: "Moderate claims with emphasis on general wellness and muscle function",
          strengthVsCompetitors:
            "Strong brand recognition; B6 combination product offers unique claim pathway",
        },
        naturesBounty: {
          currentProducts: [
            "Magnesium 500mg",
            "Magnesium Glycinate",
            "Calm & Sleep Magnesium Gummies",
          ],
          positioning: "Accessible, mass-market, value-oriented",
          claimApproach: "Consumer-friendly language, sleep-adjacent claims on gummy formats",
          strengthVsCompetitors:
            "Widest distribution; gummy format appeals to compliance-challenged consumers",
        },
      },
      externalCompetitors: [
        {
          brand: "Thorne",
          product: "Magnesium Bisglycinate",
          threat: "High",
          notes:
            "Strong practitioner channel presence. Invests heavily in clinical evidence. Direct competitor to Pure Encapsulations.",
        },
        {
          brand: "NOW Foods",
          product: "Magnesium Glycinate",
          threat: "Medium",
          notes:
            "Price leader in natural channel. Claims are conservative but distribution is extensive.",
        },
        {
          brand: "Life Extension",
          product: "Neuro-Mag Magnesium L-Threonate",
          threat: "Medium-High",
          notes:
            "Differentiated form (L-threonate) with brain-specific positioning. Patented Magtein form with dedicated clinical evidence.",
        },
        {
          brand: "Natural Calm (Natural Vitality)",
          product: "Calm Magnesium Powder",
          threat: "High",
          notes:
            "Category-defining brand for magnesium+relaxation. Strong consumer awareness. Now owned by Unilever (acquired via Onnit/supplement portfolio).",
        },
      ],
    },
    formDifferentiation: {
      magnesiumGlycinate: {
        evidenceLevel: "Strong",
        bioavailability: "High (chelated amino acid form)",
        sleepRelevance:
          "Glycine component provides additional sleep-promoting effects via NMDA receptor modulation and core body temperature reduction",
        rctCount: "6 directly relevant RCTs (as of 2025)",
        bestForClaims: [
          "Supports restful sleep",
          "Promotes sleep quality",
          "Supports relaxation and calm",
        ],
      },
      magnesiumCitrate: {
        evidenceLevel: "Moderate",
        bioavailability: "Moderate-High",
        sleepRelevance:
          "Fewer sleep-specific RCTs compared to glycinate; more evidence for general magnesium repletion",
        rctCount: "3 directly relevant RCTs",
        bestForClaims: [
          "Supports magnesium levels for overall wellness",
          "Supports muscle relaxation",
        ],
      },
      magnesiumOxide: {
        evidenceLevel: "Weak for sleep claims",
        bioavailability: "Low (4-5% absorption rate)",
        sleepRelevance:
          "Minimal sleep-specific evidence; primarily used for cost-effective magnesium repletion at high elemental doses",
        rctCount: "1 directly relevant RCT with mixed results",
        bestForClaims: ["Provides magnesium to support daily needs"],
      },
      magnesiumLThreonate: {
        evidenceLevel: "Emerging",
        bioavailability: "Moderate (unique CNS penetration)",
        sleepRelevance:
          "Crosses blood-brain barrier more effectively; evidence base growing but largely from single research group (Magtein patent holder)",
        rctCount: "2 RCTs, primarily cognitive focus with secondary sleep endpoints",
        bestForClaims: [
          "Supports brain magnesium levels",
          "Supports cognitive function",
        ],
      },
    },
    keyDifferentiators: [
      "Nestle HS portfolio spans three price tiers, allowing form-specific claim strategies per brand",
      "Pure Encapsulations glycinate formulation aligns with highest-evidence form for sleep",
      "Potential for proprietary clinical trial on specific PE formulation to create defensible evidence moat",
      "B6 combination (Solgar) enables enhanced claim through cofactor synergy evidence",
    ],
    positioningStatement:
      "Nestle Health Science is uniquely positioned to own the evidence-based magnesium-for-sleep category through tiered brand strategy: Pure Encapsulations leads with practitioner-grade glycinate backed by the strongest form-specific evidence, Solgar captures the informed consumer with heritage credibility and synergistic formulations, and Nature's Bounty democratizes access through compliant, consumer-friendly formats. No single competitor can match this multi-channel, multi-form evidence strategy.",
  },

  redCloverMenopause: {
    ingredient: "Red Clover (Trifolium pratense) Isoflavones",
    claimArea: "Menopause Symptom Support",
    evidenceStrength: {
      rating: "Moderate",
      score: 6.0,
      scaleDescription: "1-10, where 10 = multiple large RCTs with consistent positive outcomes",
      rationale:
        "Multiple RCTs demonstrate reduction in hot flash frequency and severity. Evidence is concentrated around standardized isoflavone extracts (40-80mg/day). Cochrane review (2013, updated assessments through 2024) shows modest but statistically significant effects. Mechanism well-characterized through ER-beta selective phytoestrogen activity.",
      keyLimitations: [
        "High placebo response rate in menopause trials (25-35%) complicates effect size determination",
        "Heterogeneity in extract standardization across studies",
        "Limited long-term safety data beyond 12 months",
        "Some meta-analyses show non-significant pooled effects when strictest inclusion criteria applied",
        "Regulatory sensitivity around menopause claims (disease-adjacent territory)",
      ],
    },
    competitiveLandscape: {
      nestleBrands: {
        pureEncapsulations: {
          currentProducts: [
            "Women's Pure Pack (contains isoflavones)",
            "Phyto-ADR (adaptogen complex)",
          ],
          positioning:
            "Practitioner-directed, purity-focused, part of comprehensive women's health protocols",
          claimApproach:
            "Very conservative; relies on practitioner education rather than consumer-facing claims",
          strengthVsCompetitors:
            "Trusted by integrative medicine practitioners for menopausal support protocols",
        },
        solgar: {
          currentProducts: [
            "Isoflavone Concentrate (Non-GMO Soy)",
            "Herbal Female Complex",
          ],
          positioning: "Established botanical expertise, heritage formulations",
          claimApproach:
            "Structure/function claims focused on 'supporting women during menopause transition'",
          strengthVsCompetitors:
            "Long market presence in women's health botanicals; consumer trust",
        },
        gardenOfLife: {
          currentProducts: [
            "mykind Organics Women's Multi 40+",
            "Raw Probiotics Women 50 & Wiser",
          ],
          positioning: "Organic, whole-food based, clean label",
          claimApproach:
            "Holistic women's wellness rather than symptom-specific menopause claims",
          strengthVsCompetitors:
            "Appeals to the natural/organic consumer segment; certified formulations",
        },
      },
      externalCompetitors: [
        {
          brand: "Promensil",
          product: "Promensil Menopause (Red Clover Isoflavones)",
          threat: "Very High",
          notes:
            "Category leader specifically for red clover + menopause. Standardized extract with dedicated clinical trial program. 7+ published RCTs on their specific extract. Strong regulatory dossier.",
        },
        {
          brand: "Remifemin (Schaper & Brummer)",
          product: "Remifemin (Black Cohosh, not red clover)",
          threat: "High (adjacent)",
          notes:
            "Dominant menopausal botanical supplement globally. Different ingredient but competes for same consumer need. Extensive German Commission E backing.",
        },
        {
          brand: "Estroven (i-Health/DSM)",
          product: "Estroven Menopause Relief",
          threat: "High",
          notes:
            "Strong mass-market presence. Soy isoflavone based. Heavy DTC advertising. Competes directly with Nature's Bounty channel.",
        },
        {
          brand: "Bonafide Health",
          product: "Relizen (pollen extract)",
          threat: "Medium-High",
          notes:
            "OB/GYN recommended, hormone-free positioning. Different mechanism but same consumer. Growing rapidly in practitioner channel.",
        },
      ],
    },
    formDifferentiation: {
      standardizedExtract40mg: {
        evidenceLevel: "Strongest",
        standardization: "40mg total isoflavones (biochanin A, formononetin, genistein, daidzein)",
        rctCount: "8+ RCTs at this dose range",
        bestForClaims: [
          "Supports comfort during menopause",
          "Helps manage hot flashes associated with menopause",
        ],
      },
      standardizedExtract80mg: {
        evidenceLevel: "Strong",
        standardization: "80mg total isoflavones",
        rctCount: "5 RCTs, generally showing stronger effects than 40mg",
        bestForClaims: [
          "Supports reduction in menopausal discomfort",
          "Supports thermoregulation during menopause transition",
        ],
      },
      wholeHerbPowder: {
        evidenceLevel: "Weak",
        standardization: "Variable isoflavone content",
        rctCount: "1-2 RCTs with inconsistent results",
        bestForClaims: ["Traditional use for women's wellness"],
      },
    },
    keyDifferentiators: [
      "Nestle HS has no dedicated red clover menopause product - greenfield opportunity",
      "Pure Encapsulations brand trust with HCPs (OB/GYNs, integrative MDs) is a distribution advantage",
      "Portfolio includes probiotics (Garden of Life) enabling combination menopause solutions (gut-hormone axis)",
      "Solgar's existing isoflavone expertise provides formulation foundation",
    ],
    positioningStatement:
      "Red clover isoflavones represent a strategic expansion opportunity for Nestle Health Science's women's health portfolio. By developing a standardized 80mg isoflavone extract under the Pure Encapsulations brand with a dedicated clinical trial, Nestle HS can challenge Promensil's category leadership while leveraging cross-portfolio synergies with Garden of Life probiotics for a differentiated gut-hormone menopause support platform.",
  },

  collagenSkinElasticity: {
    ingredient: "Collagen Peptides (Hydrolyzed Collagen)",
    claimArea: "Skin Elasticity & Skin Health",
    evidenceStrength: {
      rating: "Strong",
      score: 8.0,
      scaleDescription: "1-10, where 10 = multiple large RCTs with consistent positive outcomes",
      rationale:
        "Robust and growing RCT evidence base demonstrating significant improvements in skin elasticity, hydration, and wrinkle depth. Multiple systematic reviews and meta-analyses (2019-2025) consistently show positive effects. Bioactive peptide mechanism well-characterized. Japanese FFC system has approved numerous collagen+skin claims based on systematic reviews.",
      keyLimitations: [
        "Industry funding prevalent across most RCTs (potential bias)",
        "No EFSA-authorized health claims for collagen (Article 13 application was withdrawn)",
        "Dose heterogeneity (2.5g-10g/day) complicates optimal dose determination",
        "Type I vs. Type II vs. mixed collagen sourcing varies across studies",
        "Marine vs. bovine vs. porcine source may have different efficacy profiles",
      ],
    },
    competitiveLandscape: {
      nestleBrands: {
        vitalProteins: {
          currentProducts: [
            "Collagen Peptides (Unflavored)",
            "Marine Collagen",
            "Beauty Collagen (with HA & Probiotics)",
            "Collagen Creamer",
            "Collagen Bars",
          ],
          positioning:
            "Category-defining lifestyle collagen brand. Celebrity endorsement (Jennifer Aniston). Premium but accessible.",
          claimApproach:
            "Beauty-from-within messaging; structure/function claims on skin, hair, nail, and joint support",
          strengthVsCompetitors:
            "Market leader in collagen supplements. Strongest brand awareness. Broadest product format range.",
        },
        gardenOfLife: {
          currentProducts: [
            "Grass Fed Collagen Peptides",
            "Plant-Based Collagen Builder (non-collagen, contains collagen-supporting nutrients)",
          ],
          positioning: "Clean, organic, traceable sourcing",
          claimApproach: "Emphasizes sourcing quality and co-nutrient support for collagen synthesis",
          strengthVsCompetitors:
            "Appeals to organic-first consumers; unique plant-based collagen builder for vegan market",
        },
        pureEncapsulations: {
          currentProducts: [
            "Collagen JS (Joint & Skin)",
            "Hyaluronic Acid",
          ],
          positioning: "Clinical-grade, practitioner-recommended collagen",
          claimApproach:
            "Evidence-focused, references specific peptide types and clinical studies",
          strengthVsCompetitors:
            "Highest credibility in practitioner channel for collagen",
        },
      },
      externalCompetitors: [
        {
          brand: "Sports Research",
          product: "Collagen Peptides",
          threat: "High",
          notes:
            "Amazon #1 seller in collagen category. Aggressive pricing. Strong consumer reviews. Minimal clinical differentiation.",
        },
        {
          brand: "Further Food",
          product: "Collagen Peptides",
          threat: "Medium",
          notes:
            "Premium positioning with functional food angle. Smaller but loyal customer base.",
        },
        {
          brand: "Reserveage (Twinlab)",
          product: "Ultra Collagen Booster",
          threat: "Medium",
          notes:
            "Patented collagen ingredients (BioCell Collagen). Clinical studies on specific patented forms. Niche but defensible.",
        },
        {
          brand: "Skinade / Dose & Co",
          product: "Beauty collagen drinks",
          threat: "Medium-High",
          notes:
            "Liquid/drink format capturing beauty-beverage trend. Growing in prestige beauty retail channels.",
        },
        {
          brand: "Verisol (Gelita)",
          product: "Bioactive Collagen Peptides",
          threat: "High (ingredient supplier)",
          notes:
            "B2B ingredient supplier with proprietary clinical evidence on specific peptide fractions for skin. Multiple brands license their data. Key question: does Vital Proteins use Verisol peptides?",
        },
      ],
    },
    formDifferentiation: {
      hydrolyzedBovinePeptides: {
        evidenceLevel: "Strong",
        molecularWeight: "2,000-5,000 Da (optimized for absorption)",
        source: "Grass-fed bovine hide",
        rctCount: "15+ RCTs for skin outcomes",
        bestForClaims: [
          "Supports skin elasticity",
          "Promotes skin hydration",
          "Supports healthy skin aging",
        ],
      },
      marineCollagenPeptides: {
        evidenceLevel: "Strong",
        molecularWeight: "1,000-3,000 Da",
        source: "Wild-caught fish (typically cod or tilapia)",
        rctCount: "8+ RCTs for skin outcomes",
        bestForClaims: [
          "Supports skin elasticity and firmness",
          "Promotes skin hydration from within",
          "Supports skin's youthful appearance",
        ],
      },
      specificPeptideFractions: {
        evidenceLevel: "Strong (for specific patented forms)",
        examples: [
          "Verisol (Gelita) - optimized for skin with dedicated skin elasticity RCTs",
          "BioCell Collagen - hydrolyzed Type II with HA and chondroitin",
          "Peptan (Rousselot) - broad application peptides with skin data",
        ],
        rctCount: "5-8 RCTs per patented form",
        bestForClaims: [
          "Clinically shown to support skin elasticity",
          "Specific peptide profile for skin support",
        ],
      },
      wholeCollagenBroth: {
        evidenceLevel: "Weak",
        notes:
          "Minimal RCT evidence for skin outcomes. Variable peptide profile. Cultural/traditional appeal but poor regulatory claim support.",
        rctCount: "0-1 RCTs",
        bestForClaims: ["Provides collagen protein to support daily nutrition"],
      },
    },
    keyDifferentiators: [
      "Vital Proteins is the #1 collagen brand globally - massive brand equity and consumer trust",
      "Multi-format strategy (powder, capsule, gummy, bar, creamer) provides unmatched consumer touchpoints",
      "Jennifer Aniston partnership drives unparalleled awareness in beauty-from-within category",
      "Opportunity to invest in proprietary Vital Proteins clinical trial to create owned evidence",
      "Pure Encapsulations + Vital Proteins dual-channel strategy covers HCP and DTC simultaneously",
    ],
    positioningStatement:
      "Nestle Health Science, through Vital Proteins, already owns the consumer conversation on collagen. The strategic imperative is to convert brand leadership into evidence leadership by investing in large-scale, Vital Proteins-specific RCTs for skin elasticity, thereby creating an unassailable evidence moat. Supplementing this with Pure Encapsulations for the clinical channel creates a full-spectrum evidence-to-consumer pipeline that no competitor can replicate.",
  },
};

export const REGULATORY_GUIDANCE = {
  magnesiumSleep: {
    usStructureFunctionClaims: {
      recommended: [
        {
          claim: "Supports restful sleep",
          confidenceLevel: "High",
          substantiationBasis:
            "Multiple RCTs showing significant PSQI improvement with magnesium supplementation. Well-established GABA-mediated mechanism.",
          riskAssessment: "Low",
          notes:
            "Broad, well-supported claim. Avoids disease implication. Consistent with existing market claims.",
        },
        {
          claim: "Promotes relaxation and calm to support a good night's sleep",
          confidenceLevel: "High",
          substantiationBasis:
            "Magnesium's role in nervous system function and GABA modulation. Multiple human studies on subjective relaxation and sleep quality.",
          riskAssessment: "Low",
          notes:
            "Dual benefit claim (relaxation + sleep) supported by overlapping evidence base.",
        },
        {
          claim: "Helps support sleep quality",
          confidenceLevel: "Moderate-High",
          substantiationBasis:
            "RCTs using PSQI as primary endpoint show improvement in overall sleep quality scores.",
          riskAssessment: "Low-Moderate",
          notes:
            "'Quality' is measurable via validated instruments, strengthening defensibility.",
        },
      ],
      cautionary: [
        {
          claim: "Helps you fall asleep faster",
          confidenceLevel: "Moderate",
          substantiationBasis:
            "Some but not all RCTs show improvement in sleep onset latency. Effect size is modest.",
          riskAssessment: "Moderate",
          notes:
            "More specific claim requires more specific evidence. Could invite scrutiny on effect size and consistency.",
        },
        {
          claim: "Clinically proven to improve sleep",
          confidenceLevel: "Low",
          substantiationBasis:
            "'Clinically proven' sets a high evidentiary bar. While clinical evidence exists, this language implies a level of certainty that the evidence base may not fully support across all forms and populations.",
          riskAssessment: "High",
          notes:
            "Avoid 'clinically proven' language unless supported by brand-specific clinical trials. FTC has specifically targeted this language.",
        },
      ],
      prohibited: [
        {
          claim: "Treats insomnia",
          reason: "Disease claim. Insomnia is a diagnosable medical condition under ICD-10.",
        },
        {
          claim: "Cures sleep disorders",
          reason:
            "Disease claim and cure claim. Violates DSHEA and FTC Act.",
        },
      ],
      fdaNotification: {
        requirement:
          "Notification to FDA required within 30 days of first marketing per 21 CFR 101.93(a)",
        disclaimer:
          "This statement has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.",
        disclaimerPlacement:
          "Must appear in immediate proximity to the claim, in bold type on a contrasting background, or otherwise prominently displayed per 21 CFR 101.93(d)",
      },
    },
    euHealthClaims: {
      authorizedClaims: [
        {
          claim:
            "Magnesium contributes to normal functioning of the nervous system",
          regulation: "EU Register, Commission Regulation (EU) No 432/2012",
          claimId: "ID 389",
          conditionsOfUse:
            "At least 56.25mg magnesium per portion (15% of NRV). Target population: general adult population.",
          relevanceToSleep:
            "Indirect support for sleep positioning. Nervous system function underpins sleep regulation.",
        },
        {
          claim: "Magnesium contributes to normal psychological function",
          regulation: "EU Register, Commission Regulation (EU) No 432/2012",
          claimId: "ID 389",
          conditionsOfUse:
            "At least 56.25mg magnesium per portion (15% of NRV).",
          relevanceToSleep:
            "Can be combined with product positioning around relaxation and mental calm before sleep.",
        },
        {
          claim:
            "Magnesium contributes to a reduction of tiredness and fatigue",
          regulation: "EU Register, Commission Regulation (EU) No 432/2012",
          claimId: "ID 244",
          conditionsOfUse:
            "At least 56.25mg magnesium per portion (15% of NRV).",
          relevanceToSleep:
            "Addresses the consequence of poor sleep; can be used as part of sleep wellness product messaging.",
        },
      ],
      noDirectSleepClaim:
        "There is no EFSA-authorized health claim directly linking magnesium to sleep. Any EU marketing must rely on authorized nervous system, psychological function, or fatigue reduction claims with contextual (non-claim) product positioning.",
    },
    defensePackageStructure: {
      strength: {
        description: "Volume and quality of evidence supporting the claim",
        magnesiumSleepAssessment:
          "Moderate-Strong. Multiple RCTs, systematic reviews, and meta-analyses available. Evidence strongest for glycinate form at 200-400mg elemental magnesium.",
        keyEvidence: [
          "Abbasi et al. (2012) - RCT, n=46, significant PSQI improvement (p<0.001)",
          "Held et al. (2002) - RCT, n=12, objective PSG improvements in sleep efficiency",
          "Cao et al. (2018) - Systematic review of 3 RCTs, positive trend but called for larger studies",
          "Arab et al. (2023) - Meta-analysis of 9 RCTs, significant improvement in PSQI (WMD: -1.85, 95% CI: -2.50 to -1.21)",
          "Mah & Bhaskara (2024) - Large RCT, n=3,964, magnesium supplementation associated with better sleep quality in NHANES analysis",
        ],
      },
      consistency: {
        description:
          "Degree to which results are consistent across studies, populations, and methodologies",
        magnesiumSleepAssessment:
          "Moderate. Majority of studies show positive effects, though effect sizes vary. Some studies in specific populations (elderly, those with insomnia symptoms) show stronger effects than healthy adults.",
        inconsistencies: [
          "Effect size varies across magnesium forms (glycinate > citrate > oxide)",
          "Some studies in young, healthy populations show non-significant effects",
          "Dose-response not consistently demonstrated across all studies",
        ],
      },
      biologicalPlausibility: {
        description:
          "Scientific rationale for why the ingredient would produce the claimed effect",
        magnesiumSleepAssessment:
          "Strong. Multiple well-characterized mechanisms support magnesium's role in sleep.",
        mechanisms: [
          "GABA receptor agonism: Magnesium binds to GABA-A receptors, the primary inhibitory neurotransmitter system involved in sleep initiation",
          "NMDA receptor antagonism: Blocks excitatory glutamate signaling, promoting neural relaxation",
          "HPA axis modulation: Regulates cortisol and stress response pathways that interfere with sleep",
          "Melatonin regulation: Magnesium is a cofactor in the enzymatic conversion of serotonin to melatonin",
          "Circadian rhythm: Magnesium modulates the expression of clock genes (BMAL1, PER2) in animal models",
          "Renin-angiotensin-aldosterone system: Magnesium deficiency associated with aldosterone elevation, which disrupts sleep architecture",
        ],
      },
      mechanism: {
        description: "Specific biochemical pathway through which the effect occurs",
        primaryPathway:
          "Magnesium -> GABA-A receptor positive allosteric modulation -> increased inhibitory neurotransmission -> reduced neural excitability -> facilitation of sleep onset and maintenance",
        secondaryPathway:
          "Magnesium -> serotonin N-acetyltransferase cofactor -> melatonin biosynthesis -> circadian sleep-wake cycle regulation",
        supportingPathway:
          "Magnesium -> NMDA receptor antagonism -> reduced glutamate excitotoxicity -> parasympathetic nervous system activation -> physical relaxation",
      },
    },
    riskMatrix: {
      claimType: "Structure/Function - Sleep Support",
      overallRisk: "Low-Moderate",
      factors: [
        {
          factor: "FTC Challenge Risk",
          level: "Low",
          rationale:
            "Multiple published RCTs support a general sleep quality claim. Magnesium is a well-established nutrient with GRAS status.",
        },
        {
          factor: "NAD Challenge Risk",
          level: "Moderate",
          rationale:
            "If claim language is too specific (e.g., 'clinically proven'), competitor or consumer group could file NAD challenge. Keep language at structure/function level.",
        },
        {
          factor: "Class Action Risk",
          level: "Low",
          rationale:
            "Magnesium sleep claims are widespread in the market. Class action plaintiffs typically target outlier claims, not category-standard language.",
        },
        {
          factor: "EU Regulatory Risk",
          level: "Low (if using authorized claims only)",
          rationale:
            "Stick to authorized Article 13.1 claims. Do not imply sleep benefit in EU markets without using contextual non-claim communication strategies.",
        },
      ],
    },
  },

  redCloverMenopause: {
    usStructureFunctionClaims: {
      recommended: [
        {
          claim: "Supports comfort during the menopause transition",
          confidenceLevel: "Moderate-High",
          substantiationBasis:
            "Multiple RCTs showing reduction in hot flash frequency and severity. Standardized isoflavone extracts at 40-80mg/day.",
          riskAssessment: "Moderate",
          notes:
            "'Menopause transition' is a natural life stage, not a disease. 'Comfort' is broad enough to encompass multiple symptoms without implying treatment.",
        },
        {
          claim:
            "Provides isoflavones to support women's wellness during menopause",
          confidenceLevel: "High",
          substantiationBasis:
            "Well-established that isoflavones interact with estrogen receptors. Multiple studies in menopausal women.",
          riskAssessment: "Low",
          notes:
            "Very conservative claim. Describes ingredient function without specifying symptom reduction.",
        },
      ],
      cautionary: [
        {
          claim: "Reduces hot flashes",
          confidenceLevel: "Moderate",
          substantiationBasis:
            "Several RCTs show reduction, but effect sizes are modest and some meta-analyses show borderline significance.",
          riskAssessment: "High",
          notes:
            "'Reduces' implies measurable treatment effect. Borderline between structure/function and drug claim depending on context. FDA has issued warning letters for similar hot flash reduction claims.",
        },
        {
          claim: "Natural alternative to hormone replacement therapy",
          confidenceLevel: "Very Low",
          substantiationBasis: "No head-to-head superiority or equivalence data vs. HRT.",
          riskAssessment: "Very High",
          notes:
            "Implies drug equivalence. Could be interpreted as drug claim. HRT is a prescription treatment for a diagnosed condition.",
        },
      ],
      prohibited: [
        {
          claim: "Treats menopausal symptoms",
          reason:
            "While menopause is natural, 'treats symptoms' implies disease treatment under FDA interpretation. Menopausal vasomotor symptoms are an FDA-recognized indication for drug products.",
        },
        {
          claim: "Prevents osteoporosis during menopause",
          reason:
            "Osteoporosis is a disease. This is a prohibited disease prevention claim for a dietary supplement without an authorized health claim.",
        },
      ],
    },
    euHealthClaims: {
      status:
        "No authorized health claims for red clover or red clover isoflavones under Regulation (EC) 1924/2006",
      botanicalHoldList:
        "Red clover is included in the EFSA 'on hold' list for botanical health claims since 2010. This means existing claims used prior to the regulation may continue to be used in some member states under national transitional measures, but no new EU-wide authorized claims are available.",
      memberStateVariation:
        "Belgium, Italy, and some other member states allow certain traditional use claims for red clover under national lists. Check specific market regulations before making claims.",
    },
    defensePackageStructure: {
      strength: {
        description: "Volume and quality of evidence",
        assessment:
          "Moderate. Approximately 15-20 RCTs available, though quality varies significantly. Cochrane review provides structured evidence assessment.",
        keyEvidence: [
          "Tice et al. (2003) - RCT, n=252, Promensil vs. placebo, modest reduction in hot flashes",
          "Lipovac et al. (2012) - RCT, n=109, 80mg isoflavones, significant reduction in Kupperman Index",
          "Lambert et al. (2017) - Systematic review, 11 RCTs, positive trend for hot flash reduction",
          "Ghazanfarpour et al. (2016) - Meta-analysis, significant effect on hot flash frequency (SMD: -0.44, 95% CI: -0.78 to -0.10)",
          "Myers & Vigar (2017) - Cochrane-style review, evidence of modest benefit; called for higher quality trials",
        ],
      },
      consistency: {
        assessment:
          "Moderate-Low. Results are mixed across studies. Positive when analyzing standardized extracts at 80mg; weaker at lower doses or with unstandardized products.",
        inconsistencies: [
          "High placebo response complicates interpretation (25-35% improvement in placebo arms)",
          "Promensil-specific studies tend to be more positive than independent studies",
          "Duration-dependent effects: longer studies (12+ weeks) show stronger effects than short-term",
          "Equol-producer status may modify response (genetic subgroup analysis limited)",
        ],
      },
      biologicalPlausibility: {
        assessment: "Strong",
        mechanisms: [
          "Isoflavones (biochanin A, formononetin) are metabolized to genistein and daidzein, which bind estrogen receptors",
          "Preferential binding to ER-beta over ER-alpha (10-20x selectivity) explains tissue-specific effects and safety profile",
          "ER-beta activation in thermoregulatory centers modulates hot flash physiology",
          "Additional mechanisms: serotonin receptor interaction, antioxidant effects, influence on SHBG levels",
          "Equol (gut metabolite of daidzein) may be the primary active metabolite; only 30-50% of Western populations are equol producers",
        ],
      },
    },
    riskMatrix: {
      claimType: "Structure/Function - Menopause Support",
      overallRisk: "Moderate-High",
      factors: [
        {
          factor: "FDA Disease Claim Risk",
          level: "High",
          rationale:
            "Menopause claims are in a grey zone. While menopause is a natural process, specific symptom claims (hot flashes, night sweats) can be interpreted as disease claims because vasomotor symptoms are an FDA-approved drug indication.",
        },
        {
          factor: "FTC Substantiation Risk",
          level: "Moderate",
          rationale:
            "Evidence base is real but has gaps. FTC may question whether mixed meta-analysis results constitute 'competent and reliable scientific evidence.'",
        },
        {
          factor: "Safety Narrative Risk",
          level: "Moderate",
          rationale:
            "Phytoestrogen safety is periodically questioned in media. Any breast cancer association headlines (even if not supported by evidence) could require crisis response capability.",
        },
        {
          factor: "International Regulatory Risk",
          level: "High (EU), Moderate (Canada, Australia)",
          rationale:
            "No EFSA-authorized claims create EU market challenges. Canada NHPD has monograph pathways available. TGA requires assessed medicine listing for menopause claims.",
        },
      ],
    },
  },

  collagenSkinElasticity: {
    usStructureFunctionClaims: {
      recommended: [
        {
          claim: "Supports skin elasticity",
          confidenceLevel: "High",
          substantiationBasis:
            "Multiple RCTs using cutometry and other validated instruments show significant improvements in skin elasticity with collagen peptide supplementation (2.5-10g/day, 4-12 weeks).",
          riskAssessment: "Low",
          notes:
            "Core claim supported by robust evidence. Skin elasticity is measurable and consistently demonstrated across multiple trials.",
        },
        {
          claim: "Promotes skin hydration from within",
          confidenceLevel: "High",
          substantiationBasis:
            "Multiple RCTs showing significant improvement in skin hydration (corneometry measurements) with oral collagen peptides.",
          riskAssessment: "Low",
          notes:
            "Strong evidence base. 'From within' differentiates oral supplementation from topical products.",
        },
        {
          claim: "Supports healthy skin aging",
          confidenceLevel: "High",
          substantiationBasis:
            "Totality of evidence across skin elasticity, hydration, and wrinkle depth endpoints. Multiple systematic reviews support overall skin health benefits.",
          riskAssessment: "Low",
          notes:
            "Broad wellness claim well-supported by evidence. 'Healthy aging' positions appropriately without anti-aging drug implications.",
        },
        {
          claim:
            "Provides collagen peptides that support the body's natural collagen production",
          confidenceLevel: "High",
          substantiationBasis:
            "In vitro and in vivo evidence that collagen peptide fragments (Pro-Hyp, Hyp-Gly) stimulate fibroblast proliferation and endogenous collagen synthesis.",
          riskAssessment: "Low",
          notes:
            "Mechanistic claim supported by both preclinical and clinical evidence.",
        },
      ],
      cautionary: [
        {
          claim: "Reduces wrinkles",
          confidenceLevel: "Moderate",
          substantiationBasis:
            "Several RCTs show reduction in wrinkle depth/volume (PRIMOS 3D measurement). However, 'reduces wrinkles' is a strong cosmetic claim that may attract scrutiny.",
          riskAssessment: "Moderate",
          notes:
            "Consider 'Supports a reduction in the appearance of fine lines' as softer alternative. Also consider whether this language overlaps with OTC drug cosmetic claims.",
        },
        {
          claim: "Clinically shown to improve skin elasticity in 4 weeks",
          confidenceLevel: "Moderate (form-dependent)",
          substantiationBasis:
            "Some specific branded peptides (e.g., Verisol) have 4-week data, but only for their specific peptide composition.",
          riskAssessment: "Moderate-High",
          notes:
            "Time-specific claims require time-matched clinical data for the specific product formulation. If using Verisol peptides, this may be supportable with their data.",
        },
      ],
      prohibited: [
        {
          claim: "Treats skin aging or dermatological conditions",
          reason:
            "Skin aging pathology and dermatological conditions are disease states. Treatment claims are drug claims.",
        },
        {
          claim: "Reverses wrinkles / Turns back the clock on aging",
          reason:
            "Reversal claims imply treatment of aging as a condition. Also likely unsubstantiable as evidence shows improvement, not reversal.",
        },
      ],
    },
    euHealthClaims: {
      status:
        "No EFSA-authorized health claims for collagen peptides. Application under Article 13(5) was withdrawn by applicant before EFSA opinion.",
      workaround: {
        vitaminCProxy:
          "Vitamin C contributes to normal collagen formation for the normal function of skin (authorized claim, ID 4254). Adding vitamin C to collagen products enables this authorized claim.",
        conditionsOfUse:
          "At least 12mg vitamin C per portion (15% of NRV). Product must contain vitamin C, not just collagen.",
        limitation:
          "Claim is about vitamin C's role in collagen formation, not about supplemental collagen peptides improving skin. Contextual communication must be carefully managed.",
      },
      cosmeticRegulation:
        "In the EU, 'beauty from within' and skin appearance claims may also intersect with cosmetic product regulations (Regulation (EC) No 1223/2009). Legal review recommended for any EU skin claims on ingestible collagen products.",
    },
    defensePackageStructure: {
      strength: {
        assessment:
          "Strong. 20+ RCTs published. Multiple systematic reviews and meta-analyses. Consistent positive results across different collagen sources and peptide types.",
        keyEvidence: [
          "Proksch et al. (2014) - RCT, n=69, Verisol 2.5g/day, significant improvement in skin elasticity at 4 and 8 weeks (p<0.01)",
          "Asserin et al. (2015) - RCT, n=106, 10g collagen peptides, significant improvement in skin hydration and collagen density",
          "Bolke et al. (2019) - RCT, n=72, significant improvement in skin hydration, elasticity, roughness, and density",
          "de Miranda et al. (2021) - Systematic review and meta-analysis of 19 RCTs, consistent improvement in skin hydration and elasticity",
          "Pu et al. (2023) - Meta-analysis of 26 RCTs, significant improvement in skin hydration (SMD: 0.71), elasticity (SMD: 0.49), and wrinkles (SMD: -0.33)",
          "Inoue et al. (2016) - Demonstrated Pro-Hyp dipeptide absorption and accumulation in skin tissue in human pharmacokinetic study",
        ],
      },
      consistency: {
        assessment:
          "Strong. High degree of consistency across studies. Positive effects observed across bovine, marine, and porcine sources; across dose ranges of 2.5-10g/day; across study durations of 4-24 weeks.",
        minorInconsistencies: [
          "Optimal dose not definitively established (2.5g vs. 5g vs. 10g all show effects)",
          "Marine vs. bovine head-to-head comparisons are limited",
          "Some variance in which skin parameters improve most (elasticity more consistent than wrinkle depth)",
        ],
      },
      biologicalPlausibility: {
        assessment: "Strong",
        mechanisms: [
          "Collagen peptides are hydrolyzed to dipeptides and tripeptides (Pro-Hyp, Hyp-Gly) that are absorbed intact into the bloodstream",
          "These bioactive peptides accumulate in skin tissue (demonstrated in human PK studies)",
          "Pro-Hyp stimulates dermal fibroblast proliferation and hyaluronic acid synthesis",
          "Peptide fragments act as false degradation signals, stimulating new collagen synthesis (feedback mechanism)",
          "Increased procollagen type I and elastin mRNA expression demonstrated in fibroblast cultures exposed to collagen peptides",
          "Antioxidant properties of specific peptide sequences provide secondary skin-protective effects",
        ],
      },
    },
    riskMatrix: {
      claimType: "Structure/Function - Skin Elasticity",
      overallRisk: "Low",
      factors: [
        {
          factor: "FTC Challenge Risk",
          level: "Low",
          rationale:
            "Robust evidence base with multiple RCTs and meta-analyses. Collagen for skin is well-established in the market with widespread claim usage.",
        },
        {
          factor: "NAD Challenge Risk",
          level: "Low-Moderate",
          rationale:
            "Low for general claims. Moderate if time-specific or magnitude-specific claims are made without product-specific clinical data.",
        },
        {
          factor: "EU Regulatory Risk",
          level: "High (without vitamin C co-formulation)",
          rationale:
            "No authorized collagen skin claim in EU. Must use vitamin C proxy claim or rely on non-claim communication strategies.",
        },
        {
          factor: "Competitive Litigation Risk",
          level: "Low",
          rationale:
            "Market consensus on collagen skin benefits reduces likelihood of competitor challenges on standard claims.",
        },
      ],
    },
  },
};

export const EVIDENCE_GAPS = {
  magnesiumSleep: {
    populationGaps: [
      {
        population: "Pediatric (children and adolescents)",
        currentEvidence: "Virtually none. Most RCTs limited to adults 18+.",
        gap: "No RCT data on magnesium supplementation for sleep in children or adolescents",
        commercialRelevance: "High - growing market for children's sleep support supplements (gummies)",
        investmentPriority: "Medium",
        rationale:
          "Significant commercial opportunity but pediatric trials are expensive, require IRB scrutiny, and have longer timelines. Nature's Bounty kids' gummy line could benefit.",
      },
      {
        population: "Elderly (65+)",
        currentEvidence:
          "Limited. A few small RCTs in elderly populations show positive effects but sample sizes are small (n<50).",
        gap: "Need larger RCTs (n>200) in elderly populations with objective sleep measures (PSG or actigraphy)",
        commercialRelevance:
          "Very High - elderly population has highest prevalence of sleep disturbance and highest magnesium deficiency rates",
        investmentPriority: "High",
        rationale:
          "Demographic alignment between magnesium deficiency and sleep problems in elderly creates strong claim opportunity. Pure Encapsulations practitioner channel ideal for this segment.",
      },
      {
        population: "Pregnant and lactating women",
        currentEvidence:
          "Magnesium supplementation studied in pregnancy for other endpoints (pre-eclampsia) but not specifically for sleep.",
        gap: "No RCTs on magnesium for sleep quality during pregnancy or postpartum",
        commercialRelevance:
          "Medium-High - prenatal/postnatal supplements are a major category",
        investmentPriority: "Medium",
        rationale:
          "Safety profile of magnesium in pregnancy is well-established for other indications. Sleep-specific data would be differentiated.",
      },
      {
        population: "Shift workers and circadian disruption populations",
        currentEvidence: "No dedicated studies.",
        gap: "No evidence in populations with circadian misalignment, a growing demographic with specific sleep challenges",
        commercialRelevance: "Medium",
        investmentPriority: "Low-Medium",
        rationale:
          "Niche but growing awareness of shift work health impacts. Could be differentiated positioning for Solgar or PE.",
      },
      {
        population: "Ethnically diverse populations",
        currentEvidence:
          "Most RCTs conducted in Middle Eastern or Asian populations; limited data in Black, Hispanic, and Indigenous populations despite known disparities in both magnesium status and sleep health.",
        gap: "Lack of diversity in study populations limits generalizability of claims",
        commercialRelevance: "High - diverse consumer base is priority for mass-market brands",
        investmentPriority: "High",
        rationale:
          "Equity in evidence and inclusivity in marketing require diverse population data. Nature's Bounty mass-market positioning demands broadly applicable evidence.",
      },
    ],
    formSpecificGaps: [
      {
        form: "Magnesium Glycinate / Bisglycinate",
        rctStatus: "6 RCTs available (best-evidenced form for sleep)",
        gap: "No large (n>300) multi-center RCT. No head-to-head vs. other forms for sleep outcomes.",
        priority: "High",
      },
      {
        form: "Magnesium L-Threonate",
        rctStatus: "2 RCTs (cognitive primary endpoints, sleep secondary)",
        gap: "No sleep-primary endpoint RCT. All existing evidence from single research group with patent interest.",
        priority: "Medium-High",
      },
      {
        form: "Magnesium Taurate",
        rctStatus: "0 sleep-specific RCTs",
        gap: "Marketed for sleep/relaxation by several brands but has no direct clinical evidence for sleep",
        priority: "Medium",
      },
      {
        form: "Magnesium Oxide",
        rctStatus: "1 RCT with mixed results",
        gap: "Low bioavailability form used in many budget products. Evidence does not support sleep claims.",
        priority: "Low (form unlikely to support premium claims)",
      },
    ],
    durationGaps: [
      {
        duration: "Long-term (>6 months)",
        currentEvidence: "No RCTs beyond 12 weeks for sleep outcomes",
        gap: "Unknown whether sleep benefits are maintained with chronic supplementation or if tolerance develops",
        priority: "Medium",
      },
      {
        duration: "Acute / single-dose",
        currentEvidence: "Very limited acute dosing data for sleep",
        gap: "Consumers often expect immediate effect ('take tonight, sleep better tonight'). Acute data would support or refute this expectation.",
        priority: "Medium",
      },
    ],
    combinationProductGaps: [
      {
        combination: "Magnesium + Melatonin",
        currentEvidence: "No RCTs studying the combination vs. either ingredient alone",
        gap: "Widely marketed combination but no evidence of additive or synergistic benefit",
        priority: "High",
        commercialRelevance:
          "Very High - magnesium + melatonin is one of the top-selling sleep supplement combinations",
      },
      {
        combination: "Magnesium + L-Theanine",
        currentEvidence: "No combination RCTs",
        gap: "Both ingredients have independent sleep/relaxation evidence but combination not studied",
        priority: "Medium-High",
      },
      {
        combination: "Magnesium + Ashwagandha",
        currentEvidence: "No combination RCTs for sleep",
        gap: "Trending combination in the market. Both have individual evidence for sleep/stress support.",
        priority: "Medium",
      },
    ],
    opportunityMatrix: {
      highImpactHighFeasibility: [
        "Large RCT of magnesium glycinate (Pure Encapsulations formulation) in elderly population with PSQI + actigraphy endpoints",
        "Head-to-head comparison of magnesium glycinate vs. citrate vs. oxide for sleep quality",
      ],
      highImpactMediumFeasibility: [
        "Magnesium + melatonin combination RCT for Nature's Bounty Calm & Sleep product",
        "Ethnically diverse population sleep quality study for broad market substantiation",
      ],
      mediumImpactHighFeasibility: [
        "Systematic review and meta-analysis update incorporating 2023-2025 publications",
        "Bioavailability comparison study across magnesium forms (PK study, not efficacy)",
      ],
    },
  },

  redCloverMenopause: {
    populationGaps: [
      {
        population: "Perimenopause (early transition, age 40-50)",
        currentEvidence:
          "Most RCTs recruit postmenopausal women or late perimenopause. Very limited early perimenopause data.",
        gap: "Evidence gap for women in early menopause transition who are earliest supplement seekers",
        commercialRelevance:
          "Very High - perimenopausal women are the most active supplement purchasers in the menopause category",
        investmentPriority: "High",
      },
      {
        population: "Women with surgical menopause",
        currentEvidence: "Excluded from most RCTs",
        gap: "No evidence for women who undergo sudden (surgical) menopause, who typically have more severe symptoms",
        commercialRelevance: "Medium",
        investmentPriority: "Low-Medium",
      },
      {
        population: "Women with breast cancer history",
        currentEvidence:
          "Limited and conflicting. Some studies suggest safety, but most oncologists advise caution with phytoestrogens.",
        gap: "Critical evidence gap given consumer concern. Safety data specifically in breast cancer survivors needed.",
        commercialRelevance: "Medium (but critical for safety narrative)",
        investmentPriority: "Medium-High (safety priority, not commercial priority)",
      },
      {
        population: "Non-Caucasian women",
        currentEvidence:
          "Majority of RCTs conducted in Caucasian and Asian (primarily Iranian and Thai) populations. Very limited data in Black and Hispanic women.",
        gap: "Response may differ due to equol-producer status variation across ethnicities",
        commercialRelevance: "High",
        investmentPriority: "Medium-High",
      },
    ],
    formSpecificGaps: [
      {
        form: "Standardized 80mg isoflavone extract",
        rctStatus: "Best-evidenced form with 5+ RCTs",
        gap: "Need product-specific (Nestle HS formulation) clinical data to own evidence",
        priority: "High",
      },
      {
        form: "Fermented red clover extract",
        rctStatus: "1-2 small studies",
        gap: "Fermentation may increase equol-like metabolites; insufficient evidence to confirm",
        priority: "Medium",
      },
      {
        form: "Red clover combined with other botanicals (black cohosh, dong quai)",
        rctStatus: "Very limited combination data",
        gap: "Multi-botanical menopause formulations widely sold but lack evidence as combinations",
        priority: "Medium-High",
      },
    ],
    durationGaps: [
      {
        duration: "Long-term safety (>2 years)",
        currentEvidence: "Longest RCTs are 12 months. Some observational data extends further.",
        gap: "Long-term endometrial and breast safety data limited to observational studies",
        priority: "High (safety critical)",
      },
      {
        duration: "Durability of effect post-cessation",
        currentEvidence: "No wash-out period studies",
        gap: "Unknown whether benefits persist after stopping supplementation",
        priority: "Low-Medium",
      },
    ],
    combinationProductGaps: [
      {
        combination: "Red clover isoflavones + Probiotics",
        currentEvidence: "Emerging evidence that gut microbiome influences equol production from isoflavones",
        gap: "No RCTs testing isoflavone + probiotic combination for enhanced menopause symptom relief",
        priority: "Very High",
        commercialRelevance:
          "Very High - leverages Garden of Life probiotic expertise for cross-portfolio innovation. This is a unique Nestle HS strategic opportunity.",
      },
      {
        combination: "Red clover + Magnesium (for menopause sleep disturbance)",
        currentEvidence: "No combination studies",
        gap: "Sleep disturbance is a top menopause complaint. Combination could address both mechanisms.",
        priority: "Medium-High",
      },
    ],
    opportunityMatrix: {
      highImpactHighFeasibility: [
        "Red clover isoflavones + probiotic (equol-producing strain) combination RCT - leverages Garden of Life + Solgar portfolio synergy",
        "Updated systematic review incorporating 2022-2025 publications with subgroup analysis by equol-producer status",
      ],
      highImpactMediumFeasibility: [
        "Perimenopausal women (40-50) RCT with standardized 80mg extract under Pure Encapsulations brand",
        "Long-term (24-month) safety monitoring extension study",
      ],
      mediumImpactHighFeasibility: [
        "Equol-producer phenotyping study in diverse populations to inform personalized supplementation",
        "Consumer preference and symptom burden survey to align claim language with patient priorities",
      ],
    },
  },

  collagenSkinElasticity: {
    populationGaps: [
      {
        population: "Men",
        currentEvidence:
          "Majority of skin elasticity RCTs conducted in women (>85%). Limited male-specific data.",
        gap: "Growing male grooming and skin health market lacks gender-specific collagen evidence",
        commercialRelevance:
          "High - men's supplement and grooming market growing rapidly. Vital Proteins actively targeting male consumers.",
        investmentPriority: "Medium-High",
      },
      {
        population: "Younger adults (18-30)",
        currentEvidence:
          "Most RCTs recruit women 35-65. Very limited data in younger adults seeking preventive skin health.",
        gap: "Preventive supplementation concept for younger demographics lacks evidence",
        commercialRelevance:
          "Very High - Gen Z and Millennial consumers driving beauty-from-within trend",
        investmentPriority: "High",
      },
      {
        population: "Diverse skin types (Fitzpatrick IV-VI)",
        currentEvidence:
          "Overwhelmingly studied in light-skinned populations. Skin structure and aging patterns differ across skin types.",
        gap: "Limited evidence in darker skin tones where collagen degradation patterns and measurement techniques may differ",
        commercialRelevance: "High - inclusive marketing requires inclusive evidence",
        investmentPriority: "High",
      },
      {
        population: "Elderly (70+)",
        currentEvidence: "Some studies include 60-70 age range but very limited 70+ data",
        gap: "Advanced aging skin has different baseline collagen status and may respond differently",
        commercialRelevance: "Medium",
        investmentPriority: "Low-Medium",
      },
    ],
    formSpecificGaps: [
      {
        form: "Vital Proteins specific collagen peptide formulation",
        rctStatus: "No published RCTs on Vital Proteins branded product",
        gap: "Market-leading brand lacks product-specific clinical evidence. Relies on ingredient-level evidence.",
        priority: "Very High - strategic imperative",
        rationale:
          "Competitors like Gelita (Verisol) and Rousselot (Peptan) have product-specific data. A Vital Proteins-specific RCT would create owned, defensible evidence.",
      },
      {
        form: "Marine collagen vs. bovine collagen (head-to-head)",
        rctStatus: "No direct head-to-head RCTs for skin outcomes",
        gap: "Consumer perception that marine is superior lacks clinical backing. Opportunity to clarify evidence for portfolio optimization.",
        priority: "Medium-High",
      },
      {
        form: "Collagen gummies (low-dose format, typically 2-5g)",
        rctStatus: "No RCTs specifically on gummy format at typical gummy dose levels",
        gap: "Gummy format rapidly growing but evidence base built on powder format at 5-10g/day doses",
        priority: "High",
        rationale:
          "If gummy format delivers lower effective dose (2-3g vs. 10g), claims may be under-substantiated for this format. Critical to validate.",
      },
      {
        form: "Plant-based collagen builders (non-collagen formulations)",
        rctStatus:
          "No RCTs comparing collagen builders (vitamin C + silica + biotin + amino acids) vs. actual collagen peptides for skin elasticity",
        gap: "Garden of Life offers a plant-based collagen builder. Efficacy vs. actual collagen unknown.",
        priority: "Medium",
      },
    ],
    durationGaps: [
      {
        duration: "Long-term (>6 months)",
        currentEvidence: "A few studies extend to 12 weeks. Rare studies at 24 weeks.",
        gap: "Consumer expectation is ongoing daily use for years. Long-term efficacy and whether benefits plateau unknown.",
        priority: "Medium",
      },
      {
        duration: "Cessation / washout",
        currentEvidence: "1-2 studies suggest benefits diminish 4-8 weeks after cessation",
        gap: "Important for consumer messaging: 'continued use' messaging requires cessation data",
        priority: "Low-Medium",
      },
    ],
    combinationProductGaps: [
      {
        combination: "Collagen + Hyaluronic Acid (oral)",
        currentEvidence: "Very limited combination data. Individual evidence exists for both ingredients.",
        gap: "Vital Proteins Beauty Collagen contains HA. Combination efficacy not established beyond individual ingredient effects.",
        priority: "High",
      },
      {
        combination: "Collagen + Probiotics (gut-skin axis)",
        currentEvidence: "Emerging area. No RCTs on collagen + probiotic for skin outcomes.",
        gap: "Gut-skin axis is a hot research area. Combination could leverage Garden of Life probiotic portfolio.",
        priority: "Medium-High",
      },
      {
        combination: "Collagen + Vitamin C (enhanced synthesis)",
        currentEvidence:
          "Vitamin C's role in collagen synthesis is well-established. However, no RCTs test whether co-supplementation produces superior skin outcomes vs. collagen alone.",
        gap: "Assumed synergy widely marketed but not directly demonstrated in skin elasticity RCTs",
        priority: "Medium",
      },
    ],
    opportunityMatrix: {
      highImpactHighFeasibility: [
        "Vital Proteins branded collagen peptide RCT (n=150+) for skin elasticity, hydration, and wrinkle reduction in women 35-55",
        "Dose-response study (2.5g vs. 5g vs. 10g) to validate gummy format dosing",
      ],
      highImpactMediumFeasibility: [
        "Inclusive skin health RCT across diverse skin types (Fitzpatrick I-VI) with Vital Proteins product",
        "Marine vs. bovine head-to-head comparison for skin elasticity (informs portfolio strategy)",
        "Men's skin health RCT to support Vital Proteins male consumer expansion",
      ],
      mediumImpactHighFeasibility: [
        "Updated systematic review and meta-analysis incorporating 2024-2025 publications",
        "Consumer perception study on collagen sourcing preferences and evidence expectations",
        "Bioavailability comparison between powder, capsule, and gummy delivery formats",
      ],
    },
  },
};

export const PORTFOLIO_INSIGHTS = {
  crossPortfolioAnalysis: {
    brandIngredientMapping: {
      pureEncapsulations: {
        magnesium: {
          products: [
            "Magnesium (Glycinate)",
            "Magnesium (Citrate)",
            "Magnesium (Citrate/Malate)",
            "UltraMag Magnesium",
          ],
          channelStrength: "Practitioner/HCP (primary), DTC (secondary)",
          pricePosition: "Premium ($0.40-0.80/day)",
          evidenceOpportunity:
            "Glycinate form aligns with strongest sleep evidence. Ideal candidate for brand-specific RCT investment.",
        },
        collagen: {
          products: ["Collagen JS"],
          channelStrength: "Practitioner/HCP",
          pricePosition: "Premium ($1.00-1.50/day)",
          evidenceOpportunity:
            "Clinical positioning could differentiate from mass-market collagen. Joint + Skin dual-claim potential.",
        },
        redClover: {
          products: ["No dedicated product currently"],
          channelStrength: "N/A",
          pricePosition: "N/A",
          evidenceOpportunity:
            "Greenfield opportunity. PE brand credibility with integrative OB/GYNs creates ideal launch channel for evidence-backed red clover menopause product.",
        },
      },
      solgar: {
        magnesium: {
          products: [
            "Magnesium Citrate",
            "Chelated Magnesium",
            "Magnesium with Vitamin B6",
          ],
          channelStrength: "Natural/specialty retail, some practitioner",
          pricePosition: "Mid-Premium ($0.25-0.50/day)",
          evidenceOpportunity:
            "B6 combination is differentiated. Could commission comparative bioavailability study.",
        },
        collagen: {
          products: ["Limited collagen portfolio"],
          channelStrength: "Natural/specialty retail",
          pricePosition: "Mid-Premium",
          evidenceOpportunity: "Lower priority given Vital Proteins dominance in collagen category.",
        },
        redClover: {
          products: [
            "Isoflavone Concentrate",
            "Herbal Female Complex",
          ],
          channelStrength: "Natural/specialty retail",
          pricePosition: "Mid-Premium ($0.30-0.50/day)",
          evidenceOpportunity:
            "Existing formulation could be upgraded to standardized red clover extract. Solgar heritage brand trust supports women's health positioning.",
        },
      },
      naturesBounty: {
        magnesium: {
          products: [
            "Magnesium 500mg",
            "Magnesium Glycinate",
            "Calm & Sleep Magnesium Gummies",
          ],
          channelStrength: "Mass retail (Walmart, Target, CVS, Amazon)",
          pricePosition: "Value ($0.10-0.25/day)",
          evidenceOpportunity:
            "Calm & Sleep line directly targets sleep claim area. Needs evidence that gummy format and dose delivers clinically relevant magnesium levels.",
        },
        collagen: {
          products: [
            "Collagen Peptides with Vitamin C",
            "Optimal Solutions Hair, Skin & Nails with Collagen",
          ],
          channelStrength: "Mass retail",
          pricePosition: "Value ($0.15-0.30/day)",
          evidenceOpportunity:
            "Vitamin C co-formulation enables EU claim pathway. Hair/Skin/Nails combination claim needs substantiation as a whole.",
        },
        redClover: {
          products: ["No dedicated product"],
          channelStrength: "N/A",
          pricePosition: "N/A",
          evidenceOpportunity:
            "Mass-market menopause supplement opportunity. Would compete directly with Estroven. Needs strong evidence to enter this competitive space.",
        },
      },
      vitalProteins: {
        magnesium: {
          products: ["No dedicated magnesium product"],
          channelStrength: "N/A",
          pricePosition: "N/A",
          evidenceOpportunity:
            "Potential for magnesium-enhanced collagen sleep product (collagen + magnesium glycinate for beauty sleep positioning).",
        },
        collagen: {
          products: [
            "Collagen Peptides (multiple flavors)",
            "Marine Collagen",
            "Beauty Collagen",
            "Collagen Creamer",
            "Collagen Bars",
            "Collagen Water",
          ],
          channelStrength:
            "DTC, premium retail (Whole Foods, Target premium), Amazon",
          pricePosition: "Premium ($1.00-2.00/day)",
          evidenceOpportunity:
            "Category leader needing to convert brand leadership into evidence leadership. Product-specific RCT is #1 strategic priority.",
        },
        redClover: {
          products: ["No dedicated product"],
          channelStrength: "N/A",
          pricePosition: "N/A",
          evidenceOpportunity: "Not a natural fit for Vital Proteins brand identity.",
        },
      },
      gardenOfLife: {
        magnesium: {
          products: [
            "Whole Food Magnesium",
            "Dr. Formulated Magnesium (multiple formulations)",
          ],
          channelStrength: "Natural/organic retail, Amazon",
          pricePosition: "Mid-Premium ($0.30-0.60/day)",
          evidenceOpportunity:
            "Organic/whole-food magnesium positioning is differentiated. Dr. Formulated line has credibility for targeted health claims.",
        },
        collagen: {
          products: [
            "Grass Fed Collagen Peptides",
            "mykind Organics Plant Collagen Builder",
          ],
          channelStrength: "Natural/organic retail",
          pricePosition: "Mid-Premium ($0.50-1.00/day)",
          evidenceOpportunity:
            "Plant-based collagen builder is unique positioning for vegan market. Needs comparative evidence vs. actual collagen peptides.",
        },
        redClover: {
          products: ["No dedicated product, some women's multi formulations"],
          channelStrength: "Natural/organic retail",
          pricePosition: "Mid-Premium",
          evidenceOpportunity:
            "Probiotics expertise creates unique gut-hormone axis opportunity for menopause support. Could develop probiotic + isoflavone combination.",
        },
      },
    },
  },

  evidenceLeverageOpportunities: [
    {
      opportunity: "Magnesium Glycinate Sleep Evidence Cascade",
      description:
        "A single well-designed RCT on Pure Encapsulations Magnesium Glycinate for sleep could substantiate claims across PE, Solgar (if similar form), and directionally support Nature's Bounty glycinate products.",
      investmentEstimate: "$800K-1.2M for a well-powered (n=200) 12-week RCT",
      brandsImpacted: [
        "Pure Encapsulations (direct)",
        "Solgar (indirect, if formulation bridges)",
        "Nature's Bounty (directional support)",
      ],
      roi: "High - single investment supports claims across 3+ brands and 5+ SKUs",
    },
    {
      opportunity: "Vital Proteins Skin Elasticity RCT",
      description:
        "Brand-specific RCT using Vital Proteins Collagen Peptides for skin elasticity would create owned, defensible evidence for the market-leading collagen brand. Could be extended to include Beauty Collagen (with HA) as second arm.",
      investmentEstimate: "$600K-1M for a 12-week RCT with cutometry and hydration endpoints",
      brandsImpacted: [
        "Vital Proteins (direct)",
        "Pure Encapsulations Collagen JS (directional)",
        "Garden of Life Collagen Peptides (ingredient-level support)",
      ],
      roi: "Very High - evidence moat for category-leading brand. Marketing ROI likely >10x on evidence investment.",
    },
    {
      opportunity: "Cross-Portfolio Menopause Platform",
      description:
        "Develop evidence for a red clover isoflavone + probiotic menopause support platform that leverages Solgar's botanical expertise, Garden of Life's probiotic leadership, and Pure Encapsulations' practitioner credibility.",
      investmentEstimate: "$1.5-2M for the combination RCT program",
      brandsImpacted: [
        "Solgar (isoflavone formulation)",
        "Garden of Life (probiotic component)",
        "Pure Encapsulations (practitioner-channel combination product)",
      ],
      roi: "Medium-High - creates entirely new product category with proprietary evidence. Longer payback period but higher defensibility.",
    },
    {
      opportunity: "Beauty Sleep Cross-Claim (Magnesium + Collagen)",
      description:
        "Develop evidence for a 'beauty sleep' combination product (collagen peptides + magnesium glycinate) that simultaneously supports skin health and sleep quality. Natural brand fit for Vital Proteins.",
      investmentEstimate: "$500K-800K for a combination product pilot study",
      brandsImpacted: ["Vital Proteins (primary)", "Pure Encapsulations (secondary)"],
      roi: "Medium - novel category creation with high consumer appeal. Requires careful claim strategy to substantiate dual benefit.",
    },
  ],

  consumerInsightIntegration: {
    topConsumerQuestions: {
      magnesiumSleep: [
        {
          question: "Which type of magnesium is best for sleep?",
          searchVolume: "~110,000 monthly US searches (Google, 2025)",
          currentAnswer:
            "Glycinate/bisglycinate most commonly recommended by practitioners. Consumer confusion is high - this is an education opportunity.",
          strategicImplication:
            "Brand that owns the 'magnesium form for sleep' conversation wins category. PE glycinate is best-positioned.",
        },
        {
          question: "How much magnesium should I take for sleep?",
          searchVolume: "~74,000 monthly US searches",
          currentAnswer:
            "200-400mg elemental magnesium, typically taken 30-60 minutes before bed. Evidence supports this range.",
          strategicImplication:
            "Dosing guidance on packaging and content marketing supports consumer confidence and compliance.",
        },
        {
          question: "Can I take magnesium with melatonin?",
          searchVolume: "~45,000 monthly US searches",
          currentAnswer:
            "Generally considered safe to combine, but no clinical evidence on combination efficacy. Gap in evidence = gap in consumer confidence.",
          strategicImplication:
            "Combination product evidence gap is a major commercial opportunity. Nature's Bounty Calm & Sleep could lead here.",
        },
        {
          question: "How long does magnesium take to work for sleep?",
          searchVolume: "~38,000 monthly US searches",
          currentAnswer:
            "Clinical studies show effects typically measurable at 4-8 weeks. But consumers expect faster results. Managing expectations is key.",
          strategicImplication:
            "Onset-of-action data would be highly valuable for consumer marketing and retention.",
        },
      ],
      redCloverMenopause: [
        {
          question: "Is red clover safe for menopause?",
          searchVolume: "~22,000 monthly US searches",
          currentAnswer:
            "Generally considered safe for most women based on available RCT data (up to 12 months). Women with hormone-sensitive conditions should consult healthcare provider.",
          strategicImplication:
            "Safety narrative is primary consumer concern. Long-term safety data investment would directly address top consumer question.",
        },
        {
          question: "Red clover vs. black cohosh for menopause",
          searchVolume: "~18,000 monthly US searches",
          currentAnswer:
            "Different mechanisms: red clover = phytoestrogen (ER-beta), black cohosh = serotonergic/non-estrogenic. No head-to-head superiority data.",
          strategicImplication:
            "Comparative positioning opportunity. Head-to-head study could be category-defining but expensive and risky.",
        },
        {
          question: "Does red clover help with hot flashes?",
          searchVolume: "~15,000 monthly US searches",
          currentAnswer:
            "Evidence suggests modest benefit, particularly at 80mg isoflavone dose. Effect is real but smaller than HRT.",
          strategicImplication:
            "Consumer expectation management is critical. Overpromising leads to returns and negative reviews; underpromising loses sales.",
        },
      ],
      collagenSkinElasticity: [
        {
          question: "Does collagen really work for skin?",
          searchVolume: "~165,000 monthly US searches",
          currentAnswer:
            "Yes, multiple clinical studies show measurable improvements in skin elasticity, hydration, and wrinkle appearance with oral collagen peptides.",
          strategicImplication:
            "Consumer skepticism remains despite evidence. Brand-specific clinical evidence would be the most powerful proof point.",
        },
        {
          question: "What is the best collagen for skin?",
          searchVolume: "~135,000 monthly US searches",
          currentAnswer:
            "Type I collagen (from bovine or marine sources) is most relevant for skin. Hydrolyzed peptides (2,000-5,000 Da) are best absorbed.",
          strategicImplication:
            "Vital Proteins leads brand awareness here but lacks product-specific clinical data to claim 'best for skin' with evidence backing.",
        },
        {
          question: "How much collagen should I take for skin?",
          searchVolume: "~89,000 monthly US searches",
          currentAnswer:
            "Clinical evidence supports 2.5-10g/day. Most powder products provide 10-20g (overshoot). Gummies typically deliver 2-5g (potentially underdosed).",
          strategicImplication:
            "Dose validation study is critical, especially for gummy format. Could validate premium positioning if higher dose = better outcome.",
        },
        {
          question: "Marine vs bovine collagen for skin",
          searchVolume: "~52,000 monthly US searches",
          currentAnswer:
            "Both have evidence for skin benefits. Marine may have slightly smaller peptide size (faster absorption). No definitive head-to-head winner.",
          strategicImplication:
            "Vital Proteins offers both. Head-to-head study could optimize portfolio and marketing messaging.",
        },
      ],
    },
  },

  competitiveIntelligenceSummary: {
    topCompetitiveThreats: [
      {
        competitor: "Thorne",
        threatLevel: "High",
        areas: ["Magnesium (practitioner channel)", "Overall clinical credibility"],
        strategy:
          "Thorne is investing heavily in clinical trials and practitioner education. They are building an evidence-led brand that directly competes with Pure Encapsulations.",
        counterstrategy:
          "Accelerate PE clinical trial program. Leverage broader Nestle HS portfolio depth that Thorne cannot match.",
      },
      {
        competitor: "Gelita (Verisol) / Rousselot (Peptan)",
        threatLevel: "High (B2B ingredient level)",
        areas: ["Collagen peptides with owned clinical data"],
        strategy:
          "These ingredient suppliers have product-specific clinical trials that they license to brand partners, giving those brands instant evidence credibility.",
        counterstrategy:
          "Invest in Vital Proteins-specific RCT. Consider whether VP should partner with or differentiate from these ingredient suppliers.",
      },
      {
        competitor: "Promensil",
        threatLevel: "High (red clover specific)",
        areas: ["Red clover isoflavone menopause claims"],
        strategy:
          "Dedicated red clover brand with 7+ published RCTs on their specific extract. Category owner.",
        counterstrategy:
          "Out-invest in evidence with larger, better-designed RCTs. Leverage multi-brand Nestle HS distribution advantage that Promensil lacks.",
      },
      {
        competitor: "Unilever (OLLY, SmartyPants, Liquid I.V., Nutrafol)",
        threatLevel: "High (portfolio level)",
        areas: [
          "Mass-market supplements",
          "Beauty-from-within",
          "Overall VMHS market share",
        ],
        strategy:
          "Unilever rapidly building VMHS portfolio through acquisitions. OLLY's brand marketing is best-in-class for mass-market. Nutrafol has strong clinical evidence program.",
        counterstrategy:
          "Nestle HS has broader portfolio and deeper evidence investment capability. Need to ensure evidence investment keeps pace with Unilever's marketing investment.",
      },
      {
        competitor: "Amazon Private Label (Amazon Elements, Solimo)",
        threatLevel: "Medium-High",
        areas: ["Price competition in commodity ingredients including magnesium and collagen"],
        strategy:
          "Amazon private label drives race to bottom on price while controlling the discovery platform.",
        counterstrategy:
          "Differentiate on evidence, form quality, and brand trust. Clinical evidence creates moat that private label cannot easily replicate. Invest in Amazon brand store content highlighting clinical backing.",
      },
    ],
    marketShareEstimates: {
      magnesiumSleepCategory: {
        naturalCalm: "~18%",
        naturesBounty: "~12%",
        nowFoods: "~10%",
        pureEncapsulations: "~6% (premium segment share: ~22%)",
        solgar: "~5%",
        thorne: "~5%",
        others: "~44%",
        note: "Estimates based on retail scan data and analyst reports. Nestle HS combined share across all brands approximately 23%.",
      },
      collagenCategory: {
        vitalProteins: "~24%",
        sportsResearch: "~14%",
        gardenOfLife: "~6%",
        furtherFood: "~4%",
        greatLakesWellness: "~4%",
        others: "~48%",
        note: "Vital Proteins is clear market leader. Combined Nestle HS collagen share approximately 32% when including VP + GoL + NB.",
      },
      menopauseSupplementCategory: {
        estroven: "~28%",
        remifemin: "~15%",
        promensil: "~8%",
        amberen: "~7%",
        bonafide: "~6%",
        solgar: "~3%",
        others: "~33%",
        note: "Nestle HS significantly underweight in menopause category relative to overall VMHS market position. Major whitespace opportunity.",
      },
    },
  },
};
